Sign In

Mark Iwicki

Chairman and CEO Kala Pharmaceuticals

Mark Iwicki is a highly accomplished pharmaceutical industry leader with over 25 years of experience in managing drug development and commercialization across various therapeutic areas. He has a proven track record of leading successful high-performance companies and overseeing the launch of several groundbreaking medicines. Currently serving as the Chairman and CEO of Kala Pharmaceuticals, Mark has previously held executive positions at Civitas Therapeutics, Blend Therapeutics, Sunovion Pharmaceuticals, Sepracor, Novartis Pharmaceuticals, Astra Merck, and Merck. His expertise spans marketing, finance, business administration, and management. Mark holds an MBA in Marketing & Finance from Loyola University Maryland and a BS in Business Administration and Management from Ball State University. Furthermore, he is actively involved in several prominent organizations, serving on the Board of Directors for companies like Aimmune, Merus, Nimbus Therapeutics, Pulmatrix, and Taris Biomedical.

Mark Iwicki
Add to my network

Location

Greater Boston Area